Controlled anisotropic dynamics of tightly bound skyrmions in a synthetic ferrimagnet due to skyrmion-deformation mediated by induced uniaxial in-plane anisotropy

We study speed and skew deflection-angle dependence on skyrmion deformations of a tightly bound two-skyrmion state in a synthetic ferrimagnet. We condsider here, an in-plane uniaxial magnetocrystalline anisotropy-term in order to induce lateral shape distortions and an overall size modulation of the skyrmions due to a reduction of the effective out-of-plane anisotropy, thus affecting the skyrmion speed, skew-deflection and inducing anisotropy in these quantities with respect to the driving current-angle. Because of frustrated dipolar interactions in a synthetic ferrimagnet, sizeable skyrmion deformations can be induced with relatively small induced anisotropy constants and thus a wide range of tuneability can be achieved. We also show analytically, that a consequence of the skyrmion deformation can, under certain conditions cause a skyrmion deflection with respect to driving-current angles, unrelated to the topological charge. Results are analyzed by a combination of micromagnetic simulations and a compound particle description within the Thiele-formalism from which an over-all mobility tensor is constructed. This work offers an additional path towards in-situ tuning of skyrmion dynamics

Anaesthesia for serial whole-lung lavage in a patient with severe pulmonary alveolar proteinosis: a case report

<p>Abstract</p> <p>Introduction</p> <p>Pulmonary alveolar proteinosis is a rare condition that requires treatment by whole-lung lavage. We report a case of severe pulmonary alveolar proteinosis and discuss a safe and effective strategy for the anaesthetic management of patients undergoing this complex procedure.</p> <p>Case presentation</p> <p>A 34-year-old Caucasian man was diagnosed with severe pulmonary alveolar proteinosis. He developed severe respiratory failure and subsequently underwent serial whole-lung lavage. Our anaesthetic technique included the use of pre-oxygenation, complete lung separation with a left-sided double-lumen endotracheal tube, one-lung ventilation with positive end-expiratory pressure, appropriate ventilatory monitoring, cautious use of positional manoeuvres and single-lumen endotracheal tube exchange for short-term postoperative ventilation.</p> <p>Conclusion</p> <p>Patients with pulmonary alveolar proteinosis may present with severe respiratory failure and require urgent whole-lung lavage. We have described a safe and effective strategy for anaesthesia for whole-lung lavage. We recommend our anaesthetic technique for patients undergoing this complex and uncommon procedure.</p

Dynamics and inertia of skyrmionic spin structures

Skyrmions are topologically protected winding vector fields characterized by a spherical topology. Magnetic skyrmions can arise as the result of the interplay of various interactions, including exchange, dipolar and anisotropy energy in the case of magnetic bubbles and an additional Dzyaloshinskii-Moriya interaction in the case of chiral skyrmions. Whereas the static and low-frequency dynamics of skyrmions are already well under control, their gigahertz dynamical behaviour has not been directly observed in real space. Here, we image the gigahertz gyrotropic eigenmode dynamics of a single magnetic bubble and use its trajectory to experimentally confirm its skyrmion topology. The particular trajectory points to the presence of strong inertia, with a mass much larger than predicted by existing theories. This mass is endowed by the topological confinement of the skyrmion and the energy associated with its size change. It is thereby expected to be found in all skyrmionic structures in magnetic systems and beyond. Our experiments demonstrate that the mass term plays a key role in describing skyrmion dynamics.

Room temperature chiral magnetic skyrmion in ultrathin magnetic nanostructures

Magnetic skyrmions are chiral spin structures with a whirling configuration. Their topological properties, nanometer size and the fact that they can be moved by small current densities have opened a new paradigm for the manipulation of magnetisation at the nanoscale. To date, chiral skyrmion structures have been experimentally demonstrated only in bulk materials and in epitaxial ultrathin films and under external magnetic field or at low temperature. Here, we report on the observation of stable skyrmions in sputtered ultrathin Pt/Co/MgO nanostructures, at room temperature and zero applied magnetic field. We use high lateral resolution X-ray magnetic circular dichroism microscopy to image their chiral N\'eel internal structure which we explain as due to the large strength of the Dzyaloshinskii-Moriya interaction as revealed by spin wave spectroscopy measurements. Our results are substantiated by micromagnetic simulations and numerical models, which allow the identification of the physical mechanisms governing the size and stability of the skyrmions.Comment: Submitted version. Extended version to appear in Nature Nanotechnolog

Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial.

Background: The evidence base regarding the safety of intravenous (IV) iron therapy in patients with chronic kidney disease (CKD) is incomplete and largely based on small studies of relatively short duration. Methods: FIND-CKD (ClinicalTrials.gov number NCT00994318) was a 1-year, open-label, multicenter, prospective study of patients with nondialysis-dependent CKD, anemia and iron deficiency randomized (1:1:2) to IV ferric carboxymaltose (FCM), targeting higher (400-600 µg/L) or lower (100-200 µg/L) ferritin, or oral iron. A post hoc analysis of adverse event rates per 100 patient-years was performed to assess the safety of FCM versus oral iron over an extended period. Results: The safety population included 616 patients. The incidence of one or more adverse events was 91.0, 100.0 and 105.0 per 100 patient-years in the high ferritin FCM, low ferritin FCM and oral iron groups, respectively. The incidence of adverse events with a suspected relation to study drug was 15.9, 17.8 and 36.7 per 100 patient-years in the three groups; for serious adverse events, the incidence was 28.2, 27.9 and 24.3 per 100 patient-years. The incidence of cardiac disorders and infections was similar between groups. At least one ferritin level ≥800 µg/L occurred in 26.6% of high ferritin FCM patients, with no associated increase in adverse events. No patient with ferritin ≥800 µg/L discontinued the study drug due to adverse events. Estimated glomerular filtration rate remained the stable in all groups. Conclusions: These results further support the conclusion that correction of iron deficiency anemia with IV FCM is safe in patients with nondialysis-dependent CKD